In this review, we aimed to update the current state of knowledge regarding B7H4’s role in tumour promotion and immune evasion and summarise results from clinical trials assessing immunotherapies targeting B7H4 in solid tumours. The gene discussed is VTCN1; the disease is neoplasm.